K M Remington

779 total citations
20 papers, 583 citations indexed

About

K M Remington is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, K M Remington has authored 20 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Virology and 8 papers in Epidemiology. Recurrent topics in K M Remington's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and Herpesvirus Infections and Treatments (7 papers). K M Remington is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and Herpesvirus Infections and Treatments (7 papers). K M Remington collaborates with scholars based in United States, Germany and Australia. K M Remington's co-authors include Thomas W. North, Richard Cronn, Ceinwen A. Schreiner, Niels C. Pedersen, Yanqiu Zhu, K Wehrly, Bruce Chesebro, Ralph C. Judd, Dominique Pifat and Stephen J. Trejo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

K M Remington

18 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K M Remington United States 15 312 263 219 154 151 20 583
R J Pomerantz United States 13 411 1.3× 245 0.9× 115 0.5× 217 1.4× 98 0.6× 15 619
Mang Yu United States 10 219 0.7× 189 0.7× 298 1.4× 433 2.8× 241 1.6× 16 795
Yoshii Nishino Japan 14 152 0.5× 103 0.4× 138 0.6× 143 0.9× 41 0.3× 27 422
Adewunmi Onafuwa-Nuga United States 9 546 1.8× 280 1.1× 129 0.6× 234 1.5× 90 0.6× 10 740
S Kim United States 6 384 1.2× 239 0.9× 180 0.8× 129 0.8× 51 0.3× 9 526
Genoveffa Franchini United States 11 411 1.3× 163 0.6× 145 0.7× 173 1.1× 68 0.5× 15 766
Els J. M. Hogervorst Netherlands 11 291 0.9× 287 1.1× 127 0.6× 277 1.8× 36 0.2× 13 721
T J Matthews United States 10 494 1.6× 266 1.0× 155 0.7× 262 1.7× 130 0.9× 14 723
Bernd Schlereth Germany 6 136 0.4× 110 0.4× 198 0.9× 111 0.7× 81 0.5× 9 388
G Utter Sweden 12 183 0.6× 163 0.6× 282 1.3× 151 1.0× 71 0.5× 26 637

Countries citing papers authored by K M Remington

Since Specialization
Citations

This map shows the geographic impact of K M Remington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K M Remington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K M Remington more than expected).

Fields of papers citing papers by K M Remington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K M Remington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K M Remington. The network helps show where K M Remington may publish in the future.

Co-authorship network of co-authors of K M Remington

This figure shows the co-authorship network connecting the top 25 collaborators of K M Remington. A scholar is included among the top collaborators of K M Remington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K M Remington. K M Remington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ying, Audrey Chingzu Chang, David A. Beattie, & K M Remington. (2020). Novel spiking methods developed for anion exchange chromatography operating in a continuous process. Biotechnology and Bioengineering. 117(11). 3379–3389.
2.
3.
Mauser, Amy, et al.. (2004). Virus inactivation and protein recovery in a novel ultraviolet‐C reactor. Vox Sanguinis. 86(4). 230–238. 54 indexed citations
4.
Remington, K M, et al.. (2004). Establishing a GLP compliance program for non‐toxicology safety studies. PubMed Central. 8(2). 94–101. 3 indexed citations
5.
Trejo, Stephen J., et al.. (2003). Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process. Vox Sanguinis. 84(3). 176–187. 51 indexed citations
6.
7.
Remington, K M, Samuel Bennett, Constance M. Harris, Thomas M. Harris, & Katarzyna Bębenek. (1998). Highly Mutagenic Bypass Synthesis by T7 RNA Polymerase of Site-specific Benzo[a]pyrene Diol Epoxide-adducted Template DNA. Journal of Biological Chemistry. 273(21). 13170–13176. 28 indexed citations
8.
Smith, Robert A., K M Remington, Bradley D. Preston, Raymond F. Schinazi, & Thomas W. North. (1998). A Novel Point Mutation at Position 156 of Reverse Transcriptase from Feline Immunodeficiency Virus Confers Resistance to the Combination of (−)-β-2′,3′-Dideoxy-3′-Thiacytidine and 3′-Azido-3′-Deoxythymidine. Journal of Virology. 72(3). 2335–2340. 20 indexed citations
9.
Smith, Robert A., K M Remington, Robert M. Lloyd, Raymond F. Schinazi, & Thomas W. North. (1997). A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosides. Journal of Virology. 71(3). 2357–2362. 24 indexed citations
10.
LaCasse, Rachel, K M Remington, & Thomas W. North. (1996). The Mutation Frequency of Feline Immunodeficiency Virus Enhanced by 3'-Azido-3'-deoxythymidine. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(1). 26–32. 9 indexed citations
11.
Zhu, Yanqiu, K M Remington, & Thomas W. North. (1996). Mutants of feline immunodeficiency virus resistant to 2',3'-dideoxy-2',3'-didehydrothymidine. Antimicrobial Agents and Chemotherapy. 40(9). 1983–1987. 13 indexed citations
12.
Zhu, Yanqiu, et al.. (1996). Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidine. Antimicrobial Agents and Chemotherapy. 40(4). 953–957. 14 indexed citations
13.
Remington, K M, Yanqiu Zhu, T R Phillips, & Thomas W. North. (1994). Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase. Journal of Virology. 68(2). 632–637. 22 indexed citations
14.
Remington, K M, et al.. (1994). Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2',3'-dideoxyinosine alone and in combination with 3'-azido-3'-deoxythymidine. Antimicrobial Agents and Chemotherapy. 38(4). 861–864. 14 indexed citations
15.
Barlough, Jeffrey E., Thomas W. North, K M Remington, et al.. (1993). Feline immunodeficiency virus infection of cats as a model to test the effect of certain in vitro selection pressures on the infectivity and virulence of resultant lentivirus variants. Antiviral Research. 22(4). 259–272. 18 indexed citations
16.
Cronn, Richard, K M Remington, Bradley D. Preston, & Thomas W. North. (1992). Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2′-deoxyadenosine-5′-triphosphate. Biochemical Pharmacology. 44(7). 1375–1381. 20 indexed citations
17.
Remington, K M, Bruce Chesebro, K Wehrly, Niels C. Pedersen, & Thomas W. North. (1991). Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine. Journal of Virology. 65(1). 308–312. 72 indexed citations
18.
North, Thomas W., et al.. (1990). Characterization of reverse transcriptase from feline immunodeficiency virus.. Journal of Biological Chemistry. 265(9). 5121–5128. 58 indexed citations
19.
North, Thomas W., et al.. (1990). Direct comparisons of inhibitor sensitivities of reverse transcriptases from feline and human immunodeficiency viruses. Antimicrobial Agents and Chemotherapy. 34(8). 1505–1507. 49 indexed citations
20.
Remington, K M & Jon A. Rudbach. (1982). Pseudosecondary antibody response to LPS induced by toxins for macrophages.. PubMed. 31(6). 501–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R J Pomerantz Breakdown of academic impact, for papers by Mang Yu Breakdown of academic impact, for papers by Yoshii Nishino Breakdown of academic impact, for papers by Adewunmi Onafuwa-Nuga Breakdown of academic impact, for papers by S Kim Breakdown of academic impact, for papers by Genoveffa Franchini Breakdown of academic impact, for papers by Els J. M. Hogervorst Breakdown of academic impact, for papers by T J Matthews Breakdown of academic impact, for papers by Bernd Schlereth Breakdown of academic impact, for papers by G Utter
Rankless by CCL
2026